AzTrials
AzTrials

Fat BurnnNCT04043182

EFFECTIVENESS OF ULTRASOUND FOR LOCAL FAT TREATMENT

A study testing ultrassound in people with Fat Burn, run by São Paulo State University at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

It's evident that the literature shows good results on the use of aesthetic ultrasound in the treatment of localized fat, however, little has been explored so far, about possible psychological influences of this method and therefore, it is believed that it is pertinent to elaborate studies that include a placebo… Read more about this study

Who is it for?
Ages 18 to 30 years, women onlyHealthy volunteers can take part
Conditions the study is for
Fat Burn
What is being tested?
ultrassound
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
30 participants
Where
1 siteBrazil
Study dates
29 Jun 2019to 30 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Additional inclusion criteria included body mass index (BMI) equal to or less than 25.0 kg / m2
  • Adipose tissue thickness 2.6 cm or more in the treatment region;
  • Preserved elasticity and local tissue integrity;
  • In addition, participants had to agree not to change their daily routines during the study.

Who cannot join

  • Pregnancy.
  • Breastfeeding;
  • History of liposuction;
  • Lipolysis by injection therapy;
  • Abdominoplasty or surgery in the treatment region;
  • Weight reduction medication;
Show all 14Show fewer
  • Recent surgery in the last 12 months;
  • Implantable electrical device;
  • Neurosurgical deviation;
  • Hernia;
  • Sensory loss or dysesthesia in the treatment region;
  • Cancer;
  • Circulation problems;
  • Or chronic systemic disease such as diabetes or metabolic syndrome.

Trial locations and contacts

1 site in 1 country.

Jaqueline Lopes, master contact

66999202206

jaqueee-santosss@hotmail.com

Aryane Machado, PHD contact

16981251595

ary_machado@hotmail.com

Brazil1 site, 1 recruiting
  • Jaqueline Lopes

    Barra do Garças, Mount, 78600-000

    Jaqueline Lopes, 66999202206, jaqueee-santosss@hotmail.com

    Recruiting

Other trials in Brazil

About this study

Official title: ULTRASOUND FOR LOCAL FAT TREATMENT: A RANDOMIZED AND DOUBLE-BLIND CLINICAL TEST, CONTROLLED BY PLACEBO

It's evident that the literature shows good results on the use of aesthetic ultrasound in the treatment of localized fat, however, little has been explored so far, about possible psychological influences of this method and therefore, it is believed that it is pertinent to elaborate studies that include a placebo group, in order to measure the real effects from the exclusive application of ultrasound. Therefore, the objective of this study will be to verify the influence of the application of aesthetic ultrasound in the treatment of localized fat, using for both clinical, biochemical and functional parameters.

Read the detailed description

There will be included 30 participants, female gender, communities between 18 and 30 years, apparently Saudi, local abdominal fat, located in three groups: control (n = 10), experimental (n = 10) and placebo (n = 10) . Or group control não recebeu nenhum type of intervention. No experimental group, 10 sessões de ultrassom (Skinner brand, São Paulo) will be carried out in the previous region for 20 minutes. No placebo group will be applied ultrassom (Skinner brand, São Paulo), pormem com zerada intensities. Anthropometric avaliação e of dobras cutâneas will be carried out at this time before applying the treatment protocol. As skin folds will be measured by means of adipometers.

Conditions
Fat Burn
Being tested
ultrassound

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrassoundProcedure or surgery

    The treatment protocol will consist of 10 sessions, lasting 20 minutes. The energy level corresponding to 59 J / cm2 (177 J / cm2) and frequency of 3 MHZ, applied in the anterior region of the abdomen, in a quadrant previously delimited with a ballpoint pen, will be used. The flanks (lateral of the abdomen) will not be treated.

Study groups in NCT04043182
Study groupRoleWhat they receive
group controlNo interventionYou will not receive any type of intervention
treatment group (ultrasound)ExperimentalWill perform protocols of 10 sessions of ultrasound in the region of abdomen
Receives: Procedure: ultrassound
placebo groupPlacebo comparatorIt will perform protocols of 10 sessions of ultrasound in the region of abdomen, but the apparatus will be with zero intensities
Receives: Procedure: ultrassound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. change abdominal circumference (centimeters-cm), before and after intervention

    To measure values corresponding to the waist / quadrile ratio, metric phyta will be used, which will collect measurements in centimeters (cm). Assim, at waist circumference, it will be measured at umbigo height.

    Measured: before (day 0) and post protocol (post 8 weeks)

  2. change blood analysis (milligrams per decilitre-mg/dl ) before and after intervention

    A biochemical analysis will be carried out with the use of soro from blood collection in the antecubital vein, collected at a quantity of 10 mL as participants in the jejum study did not start and end the treatment as ultrassom. As shown below, BIOPLUS 2000 semi-automatic biochemical method will be evaluated for a dosage of parameters such as Triglycerides, Total Cholesterol, High Density Lipoprotein - HDL and Baixa Densidade Lipoprotein Estimates - LDL and Baixíssima Densidade Lipoprotein - VLDL through calculation formula Friedewald As dosagens will be carried out not the Laboratory of Biochemistry of the University Center of Vale do Araguaia - UNIVAR).

    Measured: before (day 0) and post protocol (post 8 weeks)

  3. weight (centimeters-cm)

    stadiometer (Sanny, American Medical do Brasil, São Paulo, Brazil).

    Measured: before (day 0)

Secondary outcomes (3)
  1. anthropometric characteristics anthropometric characteristics, photometry and personal satisfaction

    It will be measured by meio de uma meio de uma balança (Tanita BC554, Iron Man / Inner Scaner, Tanita, Illinois, United States) and a stadiometer (Sanny, American Medical do Brasil, São Paulo, Brazil). In this way, the height will be measured in centimeters and the weight in kilograms.

    Measured: before (day 0)

  2. change photometry - reduction of waist measurements before and after intervention

    A photograph will be taken with a professional camera of Canon Brand Powershot Sx530 Hs, with a fixed focal length and constant lighting.

    Measured: before (day 0) and post protocol (post 8 weeks)

  3. personal satisfaction of the participants treated before and after intervention

    A satisfação pessoal will be measured by means of a questionnaire, the objective of which will be to investigate these variables in a subjective way. Assim, the participants will be instructed to trace a 10 cm analog visual scale between two extremes, being 0 or "minimum possível" and 10 indicating "or more possível" for each classification. The satisfaction scale ranges from zero to ten.

    Measured: before (day 0) and post protocol (post 8 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Aug 2019
  2. Study start29 Jun 2019
  3. Primary completion25 Sep 2019 (estimated)
  4. Study completion30 Sep 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
30 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04043182
Sponsor's protocol ID
SaoPSU_univar
Acronym
n
Status last verified
Aug 2019
First submitted
12 Jul 2019
Last updated
2 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing ultrassound in people with Fat Burn, run by São Paulo State University at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jaqueline Lopes, master (66999202206, jaqueee-santosss@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

change abdominal circumference (centimeters-cm), before and after intervention (time frame: before (day 0) and post protocol (post 8 weeks)). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in